Search

everythinglearnresearchcommunity

for

Search:↓

Obesity is linked to higher metabolic syndrome and LH/FSH ratios, but no significant differences exist among PCOS phenotypes.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

The guideline offers recommendations for diagnosing and managing PCOS and its complications.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

El acetato de ciproterona trata problemas androgénicos como hirsutismo, acné, seborrea y alopecia con diferentes dosis y combinaciones.

Oral contraceptives can effectively treat acne by reducing oil production.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Women with keloid scars often have acne and hair loss, especially those with "true" keloids, indicating a possible hormonal imbalance.

Plasma protein binding significantly affects glucocorticosteroid concentration in blood, saliva, and hair.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Androgens can cause acne, excess hair, and hair loss, treatable with dermatologist-guided therapies.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Hair loss and excessive growth treated with various options, including new laser technology.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.